Grant: Strategic Projects - Group
University of Waterloo
$166,900.00
Development of novel microfluidic chips and whole column imaging detection technologies for point-of-care diagnostics
EF 2006-07
Résumé
Microfluidic-based Lab-on-a-chip (LOC) devices allow the total biomedical analysis and diagnosis to be performed efficiently and effectively through integrating all the processes onto a piece of glass or plastic plate, which offers great potential for point-of-care diagnostics. In order to achieve high sensitivity and high efficiency for point-of-care diagnosis, both the chip design and fabrication and the development of the detection technology are critical. Whole column imaging detection (WCID) is a novel detection technology for capillary isoelectric focusing (CIEF) and the whole capillary electrophoresis (CE) family, and has found wide applications particularly in biomedical and pharmaceutics. Instruments of CIEF-WCID have been commercialized (iCE280 Analyzer) by Convergent Bioscience (Toronto) since 1998. However, there are several drawbacks associated with the conventional capillary-based cartridge for other CE modes (except CIEF), as proposed by the industrial partner, Convergent Bioscience. The main technical difficulties include that the current cartridge results in low sensitivity due to its short light path and fails to provide plug-injection, which is essential to obtain high efficiency in CE-WCID. Microfluidic chip technology offers an excellent solution to the above problems because cross-linked microchannels can provide a plug-injection easily and a high aspect ratio microchannel can increase the light path significantly as compared to capillary-based cartridges. The main objective of this proposal is to develop microfluidic chips utilizing WCID technologies for point-of-care diagnostics. Microfluidic chips with different configurations will be fabricated using soft lithography technology, which will allow the iCE280 Analyzer to be more sensitive and more powerful (capable under all CE modes and capable for both analytical purpose and micro-preparative purposes). Specifically, microfluidic chips with high aspect ratios will be used to enhance the detection of UV-WCID. Microfluidic chips with tapered channels will be used to perform preparative CIEF. Laser-induced fluorescence (LIF) WCID will be developed to greatly enhance the detection sensitivity.
Programme
Strategic Projects - Group
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
336050-2006
Name nom
Pawliszyn, Janusz
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2006
Competition year année de concours
2006
Award amount
166900
Program id
STPGP
Program name en
Strategic Projects - Group
Program name fr
Projets stratégiques - De groupe
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1042
Committee name en
Strategic Projects Selection Panel - Biomedical Technologies
Committee name fr
Comité de sélection des projets stratégiques - Technologies biomédicales
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Partie
1
Nb partie
3
Application title
Development of novel microfluidic chips and whole column imaging detection technologies for point-of-care diagnostics
Keyword
NA
Application summary
Microfluidic-based Lab-on-a-chip (LOC) devices allow the total biomedical analysis and diagnosis to be performed efficiently and effectively through integrating all the processes onto a piece of glass or plastic plate, which offers great potential for point-of-care diagnostics. In order to achieve high sensitivity and high efficiency for point-of-care diagnosis, both the chip design and fabrication and the development of the detection technology are critical. Whole column imaging detection (WCID) is a novel detection technology for capillary isoelectric focusing (CIEF) and the whole capillary electrophoresis (CE) family, and has found wide applications particularly in biomedical and pharmaceutics. Instruments of CIEF-WCID have been commercialized (iCE280 Analyzer) by Convergent Bioscience (Toronto) since 1998. However, there are several drawbacks associated with the conventional capillary-based cartridge for other CE modes (except CIEF), as proposed by the industrial partner, Convergent Bioscience. The main technical difficulties include that the current cartridge results in low sensitivity due to its short light path and fails to provide plug-injection, which is essential to obtain high efficiency in CE-WCID. Microfluidic chip technology offers an excellent solution to the above problems because cross-linked microchannels can provide a plug-injection easily and a high aspect ratio microchannel can increase the light path significantly as compared to capillary-based cartridges. The main objective of this proposal is to develop microfluidic chips utilizing WCID technologies for point-of-care diagnostics. Microfluidic chips with different configurations will be fabricated using soft lithography technology, which will allow the iCE280 Analyzer to be more sensitive and more powerful (capable under all CE modes and capable for both analytical purpose and micro-preparative purposes). Specifically, microfluidic chips with high aspect ratios will be used to enhance the detection of UV-WCID. Microfluidic chips with tapered channels will be used to perform preparative CIEF. Laser-induced fluorescence (LIF) WCID will be developed to greatly enhance the detection sensitivity.